n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide has been researched along with Glioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aboagye, EO; Baguley, BC; Brady, F; Brown, GD; Denny, WA; Gamage, SA; Luthra, SK; Myers, R; Osman, S; Price, PM; Rowlinson-Busza, G | 1 |
1 other study(ies) available for n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide and Glioma
Article | Year |
---|---|
Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
Topics: Acridines; Animals; Antineoplastic Agents; Carbon Radioisotopes; Female; Glioma; HT29 Cells; Humans; Inhibitory Concentration 50; Intercalating Agents; Isotope Labeling; Melanoma; Mice; Mice, Inbred ICR; Mice, Nude; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |